Can we predict the course of a rare liver disease?
NCT ID NCT07744048
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This study looks at a rare liver condition called porto-sinusoidal vascular disease (PSVD), which is diagnosed with a liver biopsy. The researchers are collecting detailed medical information from 150 patients to track their health over time, including survival and liver-related complications. The goal is to identify factors that influence how the disease progresses and to find which patients may be at higher risk, ultimately helping doctors make better management decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve understanding of PSVD, helping doctors identify high-risk patients and manage the disease more precisely.
- What could go wrong
- This is an observational study, so it cannot prove what causes PSVD or test new treatments. The findings may not apply to all patients, and the study's size and design may limit the strength of its conclusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PORTO-SINUSOIDAL VASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Ditan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100015, China